Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation

Abstract

MiR-223 is intensely expressed in RA synovium, and overexpression of miR-223 suppresses osteoclastogenesis in vitro. This study demonstrates the possibility of gene therapy with miR-223 to treat bone destruction in RA patients.